Sponsored By

J&J Orthopedics Subsidiary Lays Off 67

The layoffs from DePuy Spine’s Monument, CO, facility, were announced as J&J continues its two-year orthopedic business restructuring.

Katie Hobbins

November 13, 2023

1 Min Read
Layoff Notice
WendellandCarolyn / iStock via Getty Images

Johnson & Johnson (J&J) subsidiary DePuy Spine, part of DePuy Synthes, recently announced that it will be laying off 67 employees from its facility in Monument, CO, according to an Oct. 30 WARN Act filing. The cuts come as J&J continues its two-year orthopedic business restructuring in a bid to improve its profitability.

DePuy Spine began migrating its supply from its Colorado facility to its Mooresville, IN, distribution center in 2020, after supply chain operation evaluations. This round of layoffs marks the company’s third since July, totaling 92 eliminated positions, and stopping manufacturing at the Colorado site.

The 67 employees effected by the layoff will be officially let go between Dec. 29, 2023, and Jan. 11, 2024.

J&J explained its plans to exit “less profitable” markets and product lines across its orthopedics business by the end of 2025 during the company’s Q323 earning call. As part of the exit, Joe Work, CFO of J&J, said there would be a short-term revenue disruption in orthopedics of around $250 million over the next two years. However, he also noted that he expected the exit would improve J&J’s ability to meet demand, resulting in accelerated growth and enhanced profitability. Total costs associated with the restructuring program, MD+DI previously reported, are estimated to be between $700 million and $800 million.

\"We are on a journey of improvement in orthopedics,\" said Joaquin Duato, J&J CEO, according to a SeekingAlpha transcript of the earnings call. \"We want to be number one and number two in every segment we compete. And that is a place where we are not there yet, but we are very confident that we are going to continue to make improvements by investing and by growing in the highest growth segments.\"

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like